Search

Investor Centre
FAQ

MXC: $0.061

Search

Skip to content

MENUMENU

Who We Are
What We Do
Why Invest
Contact us

ASX & LSE Announcements

ASX & LSE Announcements
Financial Reports
News & Media
Presentations
Research Reports & LSE News
Shareholder Info
Corporate Governance

ASX & LSE Announcements

ASX: MXC

$0.061

Monday, 20 September 2021

Latest Announcements

16/9/21ARTEMIC EU SALE APPROVAL AND CLINICAL TRIAL UPDATE 14/9/21UK IMPORT PERMIT GRANTED FOR CANNEPIL 10/9/21Update - Notification of cessation of securities - MXC 10/9/21Update - Application for quotation of securities - MXC 9/9/21s708(5)(e) Cleansing Notice 9/9/21Appendix 3Y x 6 9/9/21Notification regarding unquoted securities - MXC

I'd like to opt-in to receive:
All updates

Announcements and News

Investor Presentations

Leave this field empty if you're human:

Pharma Corporate & Financial Headquarters

Pharma European Operational Headquarters

UK

European Corporate Headquarters

Who

Our Team
We believe
Where we are

What

We research
We produce
We develop

Why

ASX & LSE Announcements
Financial Reports
Research Reports & LSE News
Shareholder Info
Corporate Governance

Privacy Policy Cookie Policy Disclaimer

© MGC Pharma 2021. All Rights Reserved.

Experience by Interactive Investor

Home
Who We Are
What We Do
Why Invest
FAQ
Contact Us